Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

100%

4 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

Phase 4
4(100.0%)
4Total
Phase 4(4)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT06523959Phase 4Recruiting

Avoiding Risks of Thrombosis and Bleeding in Surgery (ARTS) Trial

Role: lead

NCT03692715Phase 4Completed

Antibiotic Prophylaxis Before Shock Wave Lithotripsy

Role: lead

NCT04978259Phase 4Unknown

SOLIDARITY Finland Long-COVID (Remdesivir Long-term Follow-up Study of COVID Patients)

Role: lead

NCT05220280Phase 4Unknown

SOLIDARITY Finland Plus Long-COVID

Role: lead

All 4 trials loaded